Introduction mechanisms governing glucose homoeostasis in humans. A number of the drugs used as prophylaxis against, or treatment for, malaria have clinically significant metabolic Techniques for evaluation of glucose metabolism in side-effects. Of these, hypoglycaemia resulting from quinine administration is one of the most important [1] . Quinidine, humans the diastereoisomer of quinine, can also cause this compliAn accurate and promptly-available blood or plasma glucose cation [2] . The 4-aminoquinoline chloroquine is known to concentration may, on its own, be very useful clinically but influence glucose metabolism in ways which could lead to is a limited measure of glucose tolerance in a patient with a low blood glucose concentrations [3, 4] , although reports of disease such as malaria. The measurement of serum insulin chloroquine-treated patients with acute malaria who have in addition to glucose gives improved but still relatively developed hypoglycaemia are rare [5] . Recently, the crude information regarding complex, non-linear feedback quinoline methanol mefloquine has been shown to reduce between the pancreas and tissues which produce or utilise plasma glucose concentrations during a conventional prophyglucose. Because of this situation, a number of physiological lactic course in healthy young adults [6] . In all these tests and associated mathematical models have been develsituations, raised serum or plasma insulin concentrations oped which allow a better characterisation of factors which have been observed. regulate plasma glucose in humans. The maintenance of appropriate plasma glucose concenAmongst the most technically demanding and labour trations in both basal and fed states is largely a function of intensive are 'clamp' studies in which the plasma glucose the action of insulin. Counter-regulatory hormones, especoncentration, and also the serum insulin if necessary, can cially glucagon, become important only when the plasma be maintained or 'clamped' at predetermined levels through glucose starts to fall below normal. However, increased the simultaneous intravenous infusion of dextrose and insulin catecholamine and cortisol secretion in the absence of at rates which are calculated from the results of frequent hypoglycaemia occurs in stress situations including infections.
bedside plasma glucose sampling. Conventional clamp studies Other factors such as increased plasma free fatty acid are, however, concerned primarily with the direct estimation concentrations and ketonaemia may also contribute to a of insulin sensitivity (for which they are regarded as the raised basal plasma glucose. However, continued host and reference method) rather than insulin secretory capacity [7] , parasite glucose demand, impaired hepatic glycogenolysis though hyperglycaemic clamps have been recently highand gluconeogenesis, cytokine effects and the inability of lighted as an underutilised tool for assessment of beta cell the patient to take sufficient carbohydrate by mouth because responsiveness [8] . of nausea and vomiting increase the propensity to hypoglyIn an attempt to simplify the testing process but still caemia in malaria [1] . The added influence of hyperinsulinaeprovide robust estimates of pancreatic beta cell secretory mia due to antimalarial treatment can result in severe, capacity and its effect on tissue glucose uptake, two other refractory hypoglycaemia with serious neurological and approaches have been developed which provide results other sequelae if it remains undetected or inadequately consistent with those of clamp studies. The first is based on treated.
the 'minimal model', which is a compartmental analysis Several questions arise concerning the effect of antimalarial of plasma glucose and insulin concentrations during a drugs on plasma glucose and insulin concentrations. Which frequently-sampled intravenous glucose tolerance test drugs have the greatest effect on insulin secretion and why? (FSIVGTT) [9] . Estimates of insulin sensitivity (S I ), glucose Is this effect related to the total or free (unbound) plasma effectiveness (S G ) and pancreatic responsiveness (w 1 and w 2 ) concentration of the drug? Is there synergism between are generated [10] . The minimal model has been used antimalarial drugs of the same or different classes? Do the effectively to assess aspects of glucose tolerance in a variety drugs have other effects on glucose metabolism which could of different physiological situations and disease states [11] . contribute to hypoglycaemia? Are there special situations, The second approach is that which underlies Homoeostasis during either prophylactic or treatment courses, in which Model Assessment (HOMA) and Continuous Infusion of drug effects on glucose metabolism are exaggerated or, Glucose with Model Assessment (CIGMA). HOMA is conversely, attenuated? Do specific effects suggest novel applied in the fasting or post-absorptive state [12] and ways of preventing or treating hypoglycaemia? The published CIGMA involves standardised dextrose administration over data relating to these questions will be assessed in the present an hour to achieve a suprabasal but still physiological plasma review including, where possible, their reanalysis or reinglucose concentration [13] . These analyses are based on a structural computer model of the insulin-glucose feedback
The model uses basal (HOMA) or achieved (CIGMA) provide estimates of beta cell function and insulin sensitivity at the end of a 2 h dextrose infusion [22, 23] . A summary plasma glucose and insulin concentrations to provide values of beta cell function (%B) and insulin sensitivity (%S) of reanalysis of the original volunteer data [21] using this approach is shown in Figure 1 . In the case of the normal expressed in terms of those in a sample of healthy, nondiabetic Caucasian volunteers with an arbitrary mean of saline control infusion, CIGMA estimates of %B after 1 and 2 h were, as expected, similar. Quinine infusion was 100% and a logarithmic distribution for both variables.
associated with an average relative 330% increase in %B over the second hour. In the case of quinidine, the Quinine and quinidine equivalent increase in %B was much less (40%) but still statistically significant. Thus, therapeutic doses of quinine The cinchona alkaloids are known to increase insulin secretion by blocking ATP-sensitive potassium (K
have a more potent effect on the pancreatic beta cell than the same doses of quinidine, an observation which might channels in pancreatic beta cells [14] , a property shared with the sulphonylurea drugs used in the treatment of nonaccount for the apparently greater tendency for quinine to cause hypoglycaemia in clinical practice. insulin-dependent diabetes mellitus (NIDDM) [15] . Though other host and parasite-specific factors contribute to hypoglyWhen the ratio of %B after the second to that after the first hour (before and after drug) is plotted against total caemia in falciparum malaria, quinine-associated hyperinsulinaemia has been reported consistently in series of adult, plasma drug concentration (see Figure 2 ), there appears to be a log-linear relationship with a y-intercept near that of paediatric and pregnant patients from a variety of endemic areas [16] [17] [18] [19] . Hypoglycaemia during quinidine treatment the normal saline control study (a ratio close to 1.0). This could be interpreted as showing that quinine and quinidine has also been reported, though much less often [2] . This could be because it has less antimalarial use than quinine on share the same dose-beta cell response relationship but that pharmacokinetic differences account for the discrepant a world scale but, interestingly, reports of hypoglycaemia in patients receiving quinidine as an antiarrhythmic drug have results shown in Figure 1 . This hypothesis is, however, not supported by plasma concentrations of free (unbound) drug also been rare [20] .
Studies of quinine and quinidine in healthy volunteers (see Figure 3 ). As free concentrations in plasma may be a better surrogate marker of tissue drug levels than total, allow an examination of their comparative metabolic effects without the confounding influence of malaria per se. In a variables such as the binding of each diastereoisomer to beta cell K + ATP channels could determine the apparent pharmastudy of 11 young Thai adults [21] , each subject had a 2 h intravenous dextrose infusion according to an extended codynamic difference between these closely related compounds. A stereoisomer-specific response is also seen in CIGMA protocol on three occasions separated by at least a week. On each occasion, normal saline, quinine or quinidine other tissues [24] . Beta cell function might be influenced by malaria per se was infused together with the dextrose over the second hour. The order of these parallel infusions was random.
as well as treatment in ways which could invalidate the extrapolation of findings in healthy volunteers to acute Both alkaloids were given at a dose of 10 mg base kg −1 body weight. Analysis using CIGMA was not attempted illness. In a study of 10 Thai adults with uncomplicated falciparum malaria treated initially with intravenous quinine beyond 1 h data in the original report [21] . Drug-related effects on glucose metabolism were inferred from changes [25] , the same prolonged CIGMA protocol was followed in both acute illness and early convalescence. Reanalysis of the in serum insulin alone.
Recently, the CIGMA model has been extended to original plasma glucose and insulin concentrations at 1 and depressed response at greater levels of beta cell stimulation. If anything, this would protect against hyperinsulinaemic hypoglycaemia in quinine-treated patients but such an effect may be of minor clinical importance.
In a sample of gliclazide-treated patients with NIDDM, 600 mg quinine sulphate produced a mean fall in plasma glucose of approximately 1.0 mmol l −1 at peak plasma quinine compared with the plasma glucose profile when no quinine was taken [27] . A similar change was observed in a matched group of non-diabetic controls who took quinine and no drug respectively on the two test days. In the patients with NIDDM, the insulin response to the combination of quinine and gliclazide did not suggest synergism. These results indicate that combination antimalarial regimens such as quinine, quinidine and cinchonine [28] , or quinine given to a patient on failed mefloquine prophylaxis, will not they have no other unfavourable effects. In the case of diazoxide [15] , its hypotensive action would appear to limit clinical use. 2 h is summarized in Figure 4 . Geometric mean %B values at 1 and 2 h at presentation were similar to those at the In a recently-published large-scale comparative trial of quinine and artemether in Vietnamese adults with severe same times in convalescence, implying that non-severe malaria does not alter beta cell function significantly.
falciparum malaria [29] , hypoglycaemia occurred in 25% of quinine-treated patients compared with 11% of those However, %B after quinine administration was significantly less in both acute illness and convalescence compared with allocated artemether. These data confirm that hypoglycaemia is a common complication of severe malaria and that quinine values in healthy Thai volunteers of similar age (see Figure 4) . significantly increases its occurrence. The main result of the trial was that the two drugs were associated with similar This observation suggests that the beta cell response to the combined stimulus of glucose and quinine is depressed mortality rates despite concerns of emerging resistance to quinine. This suggests that quinine will remain a first-line during acute malaria and for a period of weeks after parasite clearance. In a study of patients with severe malaria in drug for malaria in tropical and other countries. whom a modified FSIVGTT was performed [26] , peak serum insulin concentrations after intravenous glucose (w 1 Chloroquine response) were not augmented by quinine pre-treatment. Thus it appears that malaria has little effect on insulin
In a study of six healthy volunteers and six patients with NIDDM [3], it was concluded that a short course of secretion at near basal levels but that it is associated with a chloroquine did not affect overall glucose tolerance in the cell K + ATP channels. Furthermore, total plasma mefloquine concentrations appear close to the same log-linear dose-beta controls but that there was an improvement in diabetic subjects. Nevertheless, there was a statistically significant cell response relationship as quinine and quinidine (see Figure 2 ) though both prophylactic and treatment levels are (P<0.01) reduction in fasting plasma glucose after chloroquine in the non-diabetic subjects. No individual values or usually less than those of the two cinchona alkaloids (<3 mg l −1 ) [33] . However, mefloquine is at least 98% summary data were reported but, as estimated from graphed mean curves, chloroquine produced an average 0.7 mmol protein-bound [33] which means that enhanced beta cell function occurs at relatively low free drug concentrations l −1 fall in basal plasma glucose which is of the order of that associated with prophylactic doses of mefloquine in young (see Figure 3) . The divergent effects of free serum quinine, quinidine and mefloquine on %B suggest that there are adults [6] . In addition, the mean basal plasma insulin was greater after chloroquine than before even if this did not drug-specific differences in the nature of beta cell K + ATP channel binding. Unfortunately, there are currently no in achieve statistical significance. HOMA analysis of mean fasting plasma glucose and insulin data before and after vitro data which allow an assessment of this. Principally because of poor solubility and irritant effects, mefloquine is chloroquine displayed in graphical form [3] suggests that beta cell function is increased by a proportion similar to that not available as a parenteral preparation and so is not used in severe malaria. Analogous to the situation with chloroin Thai volunteers who received intravenous quinidine (approximately 30%) [21] . From the results of in vitro quine, this might have contributed to the apparently low rate of mefloquine-associated hypoglycaemia. experiments (P. Smith, University of Oxford, unpublished observations), this effect is, as in the case of the cinchona alkaloids, likely to be mediated through K +
ATP channel
Other drugs blockade.
A more detailed study of the metabolic effects of There have been no reported cases of hypoglycaemia associated with the use of halofantrine, a phenanthrene chloroquine in NIDDM revealed that the drug not only increased insulin secretion but that insulin clearance was methanol related chemically to mefloquine. As in the case of mefloquine, the drug cannot be given parenterally and so reduced and peripheral glucose uptake accelerated [4] . Whether these three distinct effects operate in healthy its clinical use is restricted largely to treatment of uncomplicated cases. However, halofantrine administration is associtravellers taking chloroquine prophylaxis or in patients with malaria during acute treatment is unknown but rare reports ated with clinically significant prolongation of the electrocardiographic QT interval [34] , an effect which is of serious chloroquine-associated hypoglycaemia in situations including overdose [5, 20, 30] implies that they are of also seen with quinine. If beta cell K + ATP channel effects parallel those in myocardial K + channels, it is possible that limited biological significance. Despite concerns over toxicity, chloroquine can be given parenterally with safety in halofantrine also increases insulin secretion. This could contribute to or cause hypoglycaemia but, as with meflosevere malaria [31] . However, chloroquine-resistant malaria is now widespread and the cinchona alkaloids and, more quine, this may be an as yet unrecognised phenomenon. The combination of halofantrine and mefloquine appears recently, artemisinin derivatives, are the drugs of choice in severely ill patients [1, 29] . Thus, one situation in which particularly liable to promote serious dysrhythmias from QT effects [34] and, in clamp studies in diabetic patients, mild chloroquine metabolic effects might be important is now encountered rarely. hypoglycaemia has itself been found to prolong the QT interval [35] . Cardiotoxicity with halofantrine, especially when used in combination and other drugs influencing Mefloquine ventricular repolarisation, could thus result from direct and indirect effects mediated through K + channel activity at In a recent placebo-controlled trial in young healthy Caucasian volunteers [6] , 4 weeks of mefloquine in two sites. The artemisinin derivatives have not been associated with conventional prophylactic dose caused mild hyperinsulinaemia and a small (0.5 mmol l −1 ) but statistically significant hypoglycaemia and the proportions of patients with hypoglycaemia at study entry (8%) and during artemether treatment fall in plasma glucose. There were no such changes in the placebo group. Although subjects were not specifically (11%) in a recently-published series of adult patients with severe malaria [30] were similar. However, these compounds requested to fast, most were in the post-absorptive state when blood was taken and sampling before and after also prolong the QT interval in animals given high doses [36] and it is again possible that they also block pancreatic mefloquine or placebo was done at the same time of day in each patient. The results of reanalysis of serum glucose and beta cell K + ATP channels. However, these drugs and their active metabolites have relatively short half-lives [37, 38] . insulin concentrations using HOMA are shown in Figure 1 . Mefloquine produced an average 60% increase in beta cell Any effect on insulin secretion may thus be short-lived and of limited clinical significance. function at concentrations approaching those at steady state, a change equivalent to that after quinidine infusion in healthy Thai volunteers.
Treatment strategies Mefloquine is related chemically to the cinchona alkaloids. These data, together with the finding that insulin secretion Although drug-induced inappropriate insulin secretion may be present, estimates of %S using CIGMA [25, 39] and of by rat islets of Langerhans is increased after exposure to mefloquine albeit at concentrations higher than in human S I using the minimal model [26] have confirmed that malaria is associated with reduced insulin sensitivity. In combination plasma [32] , suggest that it also has the ability to close beta with adequate hepatic glucose production and normal hypoglycaemia [40] . Again, local availability and other effects (such as increased bleeding with the use of heparin) may be counter-regulatory capacity, this may mean that euglycaemia is maintained despite hyperinsulinaemia. Hypoglycaemia will problematic. Patients are generally easier to manage once they are able only occur when increased insulin secretion overrides these factors or the clinical situation changes such that glucose to take glucose by mouth. If quinine is implicated in hypoglycaemia, it can be stopped and an alternative production decreases or utilisation increases significantly. Nevertheless, surveillance for, and aggressive treatment of, antimalarial regimen given. Although mefloquine or halofantrine might be considered in this situation because they hypoglycaemia should be a central part of the routine management of acute falciparum malaria. Measurement of constitute a less potent hyperinsulinaemic stimulus, caution should be exercised as cardiotoxicity may result if plasma serum or plasma insulin may be available and will help to assess the contribution of antimalarial treatment to hypoglyconcentrations of quinine (which has a half-life of up to 24 h in acute malaria) are still significant as those of caemia, but the nature of current assays mean that the result may not be available in time to influence clinical mefloquine or halofantrine are increasing. Artemisinin derivatives may be a particularly useful alternative. management.
In practical terms, intravenous dextrose replacement When mefloquine and chloroquine are to be used as antimalarial prophylaxis, the traveller should probably be remains the mainstay of treatment for malaria-associated hypoglycaemia. Rapid injection of hypertonic dextrose advised as to situations, such as heavy ethanol ingestion or prolonged fasting, in which the risks of hypoglycaemia are (25 ml of a 50% w/v solution in adults or 1 ml kg −1 body weight in children) is required where neuroglycopaenia is increased. This advice should also be given when mefloquine or quinine are prescribed as standby treatment, though confirmed by blood or plasma glucose measurement, suspected where no such measurement is available, or quinine is used uncommonly in this situation. At present, there is insufficient information on halofantrine and artemisiconsidered imminent on the basis of serial blood glucose monitoring. Such treatment does not appear to be associated nin derivatives to include or exclude these potentially useful standby medications when such advice is given. with subsequent adverse metabolic problems such as 'rebound' hypoglycaemia or hypokalaemia even when the patient has already received quinine [26, 40] .
Conclusions An adjustable-rate intravenous glucose infusion (e.g. Several established antimalarial drugs are known to promote 4 mg kg −1 min −1 in adults [41] or at least 6 mg kg
insulin secretion which, in certain circumstances, may cause min −1 in children [42] ) with frequent bedside blood glucose or contribute to hypoglycaemia. The common cellular monitoring to maintain euglycaemia can be started either mechanism of action is through closure of pancreatic beta when hypoglycaemia is not severe or straight after a bolus cell K + ATP channels. Quinine is the most potent of these injection of hypertonic dextrose. There are theoretical drugs, though mefloquine appears to have significant effects concerns that sustained hyperglycaemia may fuel tissue on pancreatic beta cell function at very low plasma free acidosis [43] and perhaps worsen neurological damage due concentrations. In the context of prophylaxis or standby to malaria and/or hypoglycaemia per se [44] . Thus, although treatment, travellers may need to be advised of situations in strict euglycaemia should probably be the target, the method which drugs such as mefloquine may increase the risk of of glucose replacement may depend on the availability and hypoglycaemia. In severe falciparum malaria, early recogstandard of monitoring and treatment facilities. nition of hypoglycaemia is important, as is adequate Problems arise in patients in whom there are difficulties treatment, since the consequences of neuroglycopaenia can associated with intravenous administration of dextrosebe severe. There are no currently-available agents which containing fluids. In the case of renal impairment and can safely reverse the effects of drugs such as quinine on potential fluid overload, hypoglycaemia can be corrected by K + ATP channels in patients with hyperinsulinaemic hypoinstituting dialysis and increasing the glucose concentration glycaemia. Intravenous glucose replacement remains the of the dialysate. Hypertonic dextrose in dialysis fluid can, at mainstay of treatment but adjunctive measures such as the same time, help restore fluid balance. Where venous glucagon, somatostatin analogue and IntralipidA infusion access is difficult and the patient is not vomiting, dextrose may have a place. administration by nasogastric tube may be possible but its effect on blood glucose levels can be delayed and
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